NCT04559529View on ClinicalTrials.gov

Pharmacological Modulation of Hippocampal Activity in Psychosis 2

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 23, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Schizophrenia; Psychosis
Interventions
DRUG

Levetiracetam (LEV) 500 mg

The levetiracetam pill will look just like the placebo pill.

DRUG

Placebo

The placebo pill will look just like the levetiracetam pill, but does not contain any levetiracetam.

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT04559529 - Pharmacological Modulation of Hippocampal Activity in Psychosis 2 | Biotech Hunter | Biotech Hunter